These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12835986)
1. Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis. Martí-Bonmatí L; Fog AF; de Beeck BO; Kane P; Fagertun H Eur Radiol; 2003 Jul; 13(7):1685-92. PubMed ID: 12835986 [TBL] [Abstract][Full Text] [Related]
2. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248 [TBL] [Abstract][Full Text] [Related]
3. Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs. Jung G; Heindel W; Krahe T; Kugel H; Walter C; Fischbach R; Klaus H; Lackner K Magn Reson Imaging; 1998 Oct; 16(8):925-31. PubMed ID: 9814775 [TBL] [Abstract][Full Text] [Related]
4. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867 [TBL] [Abstract][Full Text] [Related]
5. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534 [TBL] [Abstract][Full Text] [Related]
6. MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers. Martí-Bonmatí L; Lonjedo E; Poyatos C; Casillas C Invest Radiol; 1998 Oct; 33(10):717-22. PubMed ID: 9788132 [TBL] [Abstract][Full Text] [Related]
7. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging. Kim SK; Kim SH; Lee WJ; Kim H; Seo JW; Choi D; Lim HK; Lee SJ; Lim JH AJR Am J Roentgenol; 2002 Sep; 179(3):741-50. PubMed ID: 12185056 [TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results. Sahani DV; O'Malley ME; Bhat S; Hahn PF; Saini S J Comput Assist Tomogr; 2002; 26(2):216-22. PubMed ID: 11884777 [TBL] [Abstract][Full Text] [Related]
9. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579 [TBL] [Abstract][Full Text] [Related]
10. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Wang C Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956 [TBL] [Abstract][Full Text] [Related]
11. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks]. Assaban M; Aubé C; Lebigot J; Ridereau-Zins C; Hamy A; Caron C J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779 [TBL] [Abstract][Full Text] [Related]
12. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography. Lee VS; Krinsky GA; Nazzaro CA; Chang JS; Babb JS; Lin JC; Morgan GR; Teperman LW Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606 [TBL] [Abstract][Full Text] [Related]